Figure 1.
Paxlovid™ (nirmatrelvir/ritonavir), which inhibits Mpro, may decrease hospitalization and mortality rates and prevent virus transmission, and has good oral bioavailability.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.